Clinical Trials Browser

Vinorelbine × Plasma cell × Clear all

NCT02791373 2018-04-03

ViGeM

Phase 2 Completed

Amyloidosis, Multiple Myeloma

NCT00477035 2017-01-11

Post-transplant Autologous Cytokine-induced Killer (CIK) Cells for Treatment of High Risk Hematologic Malignancies

Phase 1 Completed

Other hematologic neoplasmPlasma cell

Leukemia, Multiple Myeloma

NCT01220375 2014-04-17

PAV

Phase 2 Completed

Multiple Myeloma, Neoplasms, Plasma Cell